Cited by 142Hemoglobinopathies and Related DisordersIron Metabolism and DisordersHemoglobin structure and function

Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin

Open access
Ngo, Duyen A., Aygun, Banu, Akinsheye, Idowu, Hankins, Jane S., Bhan, Ishir, Luo, Hong Y., Steinberg, Martin H., Chui, David H. K.·2012·British Journal of Haematology

Abstract

Summary: Compound heterozygotes for sickle haemoglobin (HbS) and hereditary persistence of fetal haemoglobin (HPFH) have high fetal haemoglobin (HbF) levels but few, if any, sickle cell disease‐related complications. We studied 30 cases of HbS‐HPFH (types 1 and 2), confirmed by molecular analysis, and report the haematological features and change in HbF levels over time. These results were compared to those of patients with sickle cell anaemia or HbS‐β 0 thalassaemia, including a subgroup of patients carrying the XmnI polymorphism, known to be associated with elevated HbF. Among the HbS‐HPFH patients, HbF level was 50–90% during infancy and declined steeply within the first few years of life, stabilizing between ages 3 and 5 years, at approximately 30%. Mean HbF of individuals age 5 or older was 31 ± 3%, average haemoglobin concentration was 130 ± 10 g/l and average mean corpuscular volume (MCV) was 75 ± 4 fl. Univariate and multivariate regression analyses significantly associated HbF with age, haemoglobin concentration, and MCV ( P < 0·001). There was a strong inverse association between HbF and age ( r = −0·9, P < 0·001). Despite having a much higher HbF level, patients with HbS‐HPFH have a similar age‐related pattern of HbF decline and associations as patients with sickle cell anaemia or HbS‐β 0 thalassaemia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2141.2011.08916.x

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Individuals with HbS-HPFH do not have hemolytic anemia and are usually asymptomatic.

    “Individuals with this genotype do not have hemolytic anemia and are usually asymptomatic.50”

    From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [50]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Thein SL & Wood WG (2009) The molecular basis of β thalassemia, δ-β thalassemia, and hereditary persistence of fetal hemoglobin. In: Disorders of Hemoglobin (ed. by Steinberg MH, Forget BG, Higgs DR & Weatherall DJ). pp. 341– 345. Cambridge University Press, New York.

Cited by

Sorted by citations

Authors
Ngo, D. A., Aygun, B., Akinsheye, I., Hankins, J. S., Bhan, I., Luo, H. Y., Steinberg, M. H., & Chui, D. H. K.
Affiliations
  • Boston University (US)
  • St. Jude Children's Research Hospital (US)
  • Massachusetts General Hospital (US)
Venue
British Journal of Haematology
Publisher
Wiley
Published
2011-10-24
Volume
156
Issue
2
Pages
259-264
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W1549636655
Cited by
142
References
17
Citations by year
2026: 11 · 2025: 11 · 2024: 12 · 2023: 8 · 2022: 13 · 2021: 7 · 2020: 11 · 2019: 12 · 2018: 12 · 2017: 13 · 2016: 8 · 2015: 8 · 2014: 6 · 2013: 5 · 2012: 4
FWCI
2.60
Type
journal article
Language
en
Open access
Locations
  • British Journal of Haematology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R01HL098239, R01HL068970, U54HL070819, U54HL70819, U01HL133996)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK069646, R01DK088988)
Topics
  • Health Sciences › Medicine › Genetics › Hemoglobinopathies and Related Disorders
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hemoglobin structure and function
Keywords
fetal hemoglobin, hemoglobin S, compound heterozygosity, sickle cell disease, beta-thalassemia, XmnI polymorphism, mean corpuscular volume, hemoglobin levels
MeSH terms
Adolescent, Adult, Anemia, Sickle Cell, Child, Child, Preschool, Female, Fetal Hemoglobin, Hemoglobin, Sickle, Heterozygote, Humans, Infant, Male, Pregnancy, Sequence Deletion, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review